Ache Laboratorios Farmaceuticos SA:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Ache Laboratorios Farmaceuticos SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3401
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ブラジル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Ache Laboratorios Farmaceuticos SA (Ache) is a drug company that provides generic products. The company offers prescription, prescription free, generic, dermatological, dermocosmetic drugs, nutraceuticals and probiotic products, among others. It offers activities such as research, development, production, distribution and commercialization of biotechnology medicines, among others. Ache manufactures cephalosporin antibiotics and commercialization of functional foods. The company exports drugs Canada, Colombia, Peru, Ecuador, Chile, Bolivia, Cista Rica, Venezuela, Mexico, the US, Dominica Republic, and others. It operates through its industrial plants located in Guarulhos, Sao Paulo and Anapolis, Brazil. Ache is headquartered in Guarulhos, Brazil.

Ache Laboratorios Farmaceuticos SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Ache Laboratorios Farmaceuticos SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ache Laboratorios Farmaceuticos SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Ache Laboratorios Farmaceuticos SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ache Laboratorios Farmaceuticos SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Ache Laboratorios Farmaceuticos SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Ache Laboratorios Farmaceuticos SA, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Ferring International Center Enters into Agreement with Ache Laboratorios Farmaceuticos 10
BioGaia Enters Into Distribution Agreement With Ache Labs 11
Hypermarcas Enters Into Joint Venture With Ache Labs, EMS Participacoes And Uniao Quimica Farmaceutica 12
Acquisition 13
Ache Laboratorios Farmaceuticos Acquires Nortis Pharma 13
Pfizer, Novartis And Abbott Labs Reportedly Plan To Bid For Ache Labs 14
Ache Laboratorios Farmaceuticos SA – Key Competitors 16
Ache Laboratorios Farmaceuticos SA – Key Employees 17
Ache Laboratorios Farmaceuticos SA – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Joint Venture 18
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Ache Laboratorios Farmaceuticos SA, Pharmaceuticals & Healthcare, Key Facts 2
Ache Laboratorios Farmaceuticos SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ache Laboratorios Farmaceuticos SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Ache Laboratorios Farmaceuticos SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ache Laboratorios Farmaceuticos SA, Deals By Therapy Area, 2012 to YTD 2018 8
Ache Laboratorios Farmaceuticos SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Ferring International Center Enters into Agreement with Ache Laboratorios Farmaceuticos 10
BioGaia Enters Into Distribution Agreement With Ache Labs 11
Hypermarcas Enters Into Joint Venture With Ache Labs, EMS Participacoes And Uniao Quimica Farmaceutica 12
Ache Laboratorios Farmaceuticos Acquires Nortis Pharma 13
Pfizer, Novartis And Abbott Labs Reportedly Plan To Bid For Ache Labs 14
Ache Laboratorios Farmaceuticos SA, Key Competitors 16
Ache Laboratorios Farmaceuticos SA, Key Employees 17
Ache Laboratorios Farmaceuticos SA, Subsidiaries 18
Ache Laboratorios Farmaceuticos SA, Joint Venture 18

List of Figures
Ache Laboratorios Farmaceuticos SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Ache Laboratorios Farmaceuticos SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Ache Laboratorios Farmaceuticos SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Ache Laboratorios Farmaceuticos SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Ache Laboratorios Farmaceuticos SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ache Laboratorios Farmaceuticos SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Ache Laboratorios Farmaceuticos SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ache Laboratorios Farmaceuticos SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Ache Laboratorios Farmaceuticos SA:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SpineGuard SA (ALSGD):企業の財務・戦略的SWOT分析
    Summary SpineGuard SA (SpineGuard) is a medical device company that designs, develops and markets spine surgery products. The company offers PediGuard, a device that detects possible vertebral cortex perforation during pedicle preparation. It provides offers screw placement and alerts to surgeon pri …
  • Crown Bioscience Inc:企業のM&A・事業提携・投資動向
    Crown Bioscience Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Crown Bioscience Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • American Outdoor Brands Corp:企業の戦略・SWOT・財務情報
    American Outdoor Brands Corp - Strategy, SWOT and Corporate Finance Report Summary American Outdoor Brands Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Biohaven Pharmaceutical Holding Company Ltd (BHVN):製薬・医療:M&Aディール及び事業提携情報
    Summary Biohaven Pharmaceutical Holding Company Ltd (Biohaven), a subsidiary of Portage Biotech Inc, is a clinical-stage biopharmaceutical company that develops late-stage product candidates for neurological diseases. The company develops small molecule CGRP receptor antagonist platform that include …
  • Oiltanking GmbH:石油・ガス:M&Aディール及び事業提携情報
    Summary Oiltanking GmbH (Oiltanking), a subsidiary of Marquard & Bahls AG is an independent tank storage service provider. The company offers storage facilities and associated services for oils, petroleum products, chemicals, biofuels, gases and dry bulk. It owns and operates terminals in Europe, No …
  • Cellnovo Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Cellnovo Ltd (Cellnovo), formerly Starbridge Systems Ltd is a provider of conventional diabetes care technology solutions. The company offers mobile diabetes management systems such as insulin patch pump, cellular-enabled wireless touchscreen handset with integrated blood glucose meter, acti …
  • Summit Therapeutics Plc (SUMM):製薬・医療:M&Aディール及び事業提携情報
    Summary Summit Therapeutics Plc (Summit), formerly Summit Corp Plc is a clinical-stage drug discovery and development company that offer therapies. The company conducts research and development on the treatment of rare diseases and infectious diseases including duchenne muscular dystrophy and the in …
  • Unichem Laboratories Ltd (UNICHEMLAB):企業の財務・戦略的SWOT分析
    Summary Unichem Laboratories Ltd (Unichem) is an integrated, specialty pharmaceutical company which manufactures pharmaceutical formulations, generic products and active pharmaceutical ingredients (API's). The company offers its products in the therapeutic areas of gastroenterology, anti-invectives, …
  • Centers for Disease Control and Prevention-製薬・医療分野:企業M&A・提携分析
    Summary Centers for Disease Control and Prevention (CDC), a subsidiary of US Department of Health and Human Services is a public health institute that offers health, safety and security threat management solutions. The institute provides health information to fight diseases and support communities f …
  • Atomenergoprom:企業の戦略的SWOT分析
    Atomenergoprom - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Noni B Ltd (NBL):企業の財務・戦略的SWOT分析
    Noni B Ltd (NBL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Vozrozhdenie Bank (VZRZ):企業の財務・戦略的SWOT分析
    Summary Vozrozhdenie Bank (VB) is a banking service provider that provides corporate business, retail business, bank cards transactions and financial market operations. The company provides personal banking and business services. It products include debit and credit cards, accounts, and others. VB o …
  • Banco General SA:企業の戦略・SWOT・財務情報
    Banco General SA - Strategy, SWOT and Corporate Finance Report Summary Banco General SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Beach Energy Limited:企業の戦略・SWOT・財務情報
    Beach Energy Limited - Strategy, SWOT and Corporate Finance Report Summary Beach Energy Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Alliant Energy Corporation:企業の戦略・SWOT・財務情報
    Alliant Energy Corporation - Strategy, SWOT and Corporate Finance Report Summary Alliant Energy Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Commercial Bank Of Kuwait Sak
    Commercial Bank Of Kuwait Sak - Strategy, SWOT and Corporate Finance Report Summary Commercial Bank Of Kuwait Sak - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Fauji Fertilizer Bin Qasim Limited (FFBL)-エネルギー分野:企業M&A・提携分析
    Summary Fauji Fertilizer Bin Qasim Limited (FFBL) is a chemical manufacturing company that manufactures, supplies and markets di ammonium phosphate (DAP) and granular urea. In addition, the company undertakes production and marketing of ammonia and other nitrogenous fertilizers for agricultural appl …
  • TMX Group Ltd (X)
    TMX Group Ltd (X) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Silence Therapeutics Plc (SLN)-製薬・医療分野:企業M&A・提携分析
    Summary Silence Therapeutics plc (Silence Therapeutics), formerly SR Pharma plc is a research and development company that develops and delivers RNA interference therapeutics for the treatment of serious diseases. The company's pipeline products include Atu027 and Atu111. Its Atu027 is developed for …
  • SPX Flow Inc (FLOW):企業の財務・戦略的SWOT分析
    SPX Flow Inc (FLOW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆